Bacterial samples
|
Antibiotic
|
---|
CIP
|
LEV
|
OFX
|
CN
|
TOB
|
AK
|
PRL
|
TZP
|
IPM
|
CAZ
|
ATM
|
PB
|
---|
Ps 1
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
Ps 2
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
I
|
S
|
Ps 3
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
I
|
Ps 4
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
Ps 5
|
I
|
S
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
S
|
Ps 6
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
R
|
R
|
S
|
Ps 7
|
I
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
S
|
Ps 8
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
Ps 9
|
S
|
S
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
S
|
Ps 10
|
S
|
S
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
S
|
Ps 11
|
R
|
S
|
S
|
R
|
S
|
S
|
S
|
R
|
S
|
R
|
S
|
S
|
Ps 12
|
R
|
S
|
S
|
R
|
S
|
S
|
S
|
S
|
S
|
I
|
R
|
S
|
Ps 13
|
S
|
S
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
R
|
S
|
- The diameters of the inhibition zones were interpreted according to CLSI (2016), and the examined isolates were reported as R resistant, I intermediate, S sensitive, CN gentamycin, TOB tobramycin, AK amikacin, IMP imipenem, CAZ ceftazidime, CIP ciprofloxacin, OFX oflaxacin, LEV levofloxacin, TZP piperacillin-tazobactum, PRL piperacillin, ATM aztreonam, PB polymyxin B